Your browser doesn't support javascript.
loading
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Larson, Richard A; Mandrekar, Sumithra J; Huebner, Lucas J; Sanford, Ben L; Laumann, Kristina; Geyer, Susan; Bloomfield, Clara D; Thiede, Christian; Prior, Thomas W; Döhner, Konstanze; Marcucci, Guido; Voso, Maria Teresa; Klisovic, Rebecca B; Galinsky, Ilene; Wei, Andrew H; Sierra, Jorge; Sanz, Miguel A; Brandwein, Joseph M; de Witte, Theo; Niederwieser, Dietger; Appelbaum, Frederick R; Medeiros, Bruno C; Tallman, Martin S; Krauter, Jürgen; Schlenk, Richard F; Ganser, Arnold; Serve, Hubert; Ehninger, Gerhard; Amadori, Sergio; Gathmann, Insa; Döhner, Hartmut; Stone, Richard M.
Afiliação
  • Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA. rlarson@medicine.bsd.uchicgo.edu.
  • Mandrekar SJ; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Huebner LJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Sanford BL; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Laumann K; Alliance Statistics and Data Center, Duke University, Durham, NC, USA.
  • Geyer S; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Bloomfield CD; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Thiede C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Prior TW; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
  • Döhner K; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Marcucci G; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Voso MT; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Klisovic RB; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  • Galinsky I; Emory University School of Medicine, Atlanta, GA, USA.
  • Wei AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sierra J; Department of Clinical Haematology, The Alfred Hospital and Monash University, Melbourne, Australia.
  • Sanz MA; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Leukemia Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
  • Brandwein JM; Department of Hematology, Hospital Universitario y Politécnico La Fe and Department of Medicine, University of Valencia, Valencia, Spain.
  • de Witte T; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Niederwieser D; Radboud University Medical Centre, Nijmegen, Netherlands.
  • Appelbaum FR; Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
  • Medeiros BC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Tallman MS; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA.
  • Krauter J; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Schlenk RF; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ganser A; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Serve H; NCT Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Ehninger G; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Amadori S; Department of Medicine II, Hematology/Oncology, Goethe University Hospital Frankfurt, Frankfurt/Main, Germany.
  • Gathmann I; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
  • Döhner H; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
  • Stone RM; Novartis Pharma AG, Basel, Switzerland.
Leukemia ; 35(9): 2539-2551, 2021 09.
Article em En | MEDLINE | ID: mdl-33654204
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Estaurosporina / Tirosina Quinase 3 Semelhante a fms / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Estaurosporina / Tirosina Quinase 3 Semelhante a fms / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos